Management of Myocardial Infarction: Emerging Paradigms for the Future.
Vandan D UpadhyayaChristopher WongRamzan M ZakirNima AghiliHaroon FarazNavin K KapurPublished in: Methodist DeBakey cardiovascular journal (2024)
Despite significant advancements in managing acute ST-segment elevation myocardial infarctions, the prevalence of heart failure has not decreased. Emerging paradigms with a focus on reducing infarct size show promising evidence in the improvement of the incidence of heart failure after experiencing acute coronary syndromes. Limiting infarct size has been the focus of multiple clinical trials over the past decades and has led to left ventricular (LV) unloading as a potential mechanism. Contemporary use of microaxial flow devices for LV unloading has suggested improvement in mortality in acute myocardial infarction complicated by cardiogenic shock. This review focuses on clinical data demonstrating evidence of infarct size reduction and highlights ongoing clinical trials that provide a new therapeutic approach to the management of acute myocardial infarction.
Keyphrases
- acute myocardial infarction
- left ventricular
- heart failure
- clinical trial
- cardiac resynchronization therapy
- hypertrophic cardiomyopathy
- risk factors
- percutaneous coronary intervention
- aortic stenosis
- acute coronary syndrome
- mitral valve
- left atrial
- liver failure
- respiratory failure
- randomized controlled trial
- cardiovascular events
- hepatitis b virus
- open label
- phase ii
- antiplatelet therapy
- intensive care unit
- risk assessment
- atrial fibrillation
- artificial intelligence
- drug induced
- big data
- aortic dissection
- double blind